54V-43126-08760
3 vaccinations
5 coded responses
15 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 482 / MI
- Registered
- 2021-11-01
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Moderna
-
2021-03-06
Dose 2 — Moderna
-
2021-11-01
Registered in v-safe
-
2021-11-01
Dose 3 — Moderna
- 2021-11-01
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema, Injection site induration, Injection site swelling — Feeling: Fair · Site: Pain, Redness, Swelling, ItchingFree text: It's day 4 and the redness at the injection site has not gone away neither has the swelling and it feels hard. Does this mean that the injection was subcutaneous? If so, was the vaccine absorbed or do I have to get another booster?MedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Good · Site: Redness, ItchingFree text: I'm still concerned that this injection was subcutaneous instead of intramuscular. I'm wondering did the vaccine absorb properly or do I need a fourth dose. I would appreciate an answer.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — day 7, dose 3MedDRA: Injection site erythema, Unevaluable event — Feeling: Good · Site: RednessFree text: Arm remains red at the injection site. I remain concerned about absorption. No Phine call from the CDC to date.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-15
- 2021-11-22
-
2021-11-29
Survey response — day 28, dose 3MedDRA: Arthralgia, Injection site discolouration, Injection site pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: The injection site on my right arm remains sore. No swelling or redness but the skin is dark and my shoulder achesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Survey response — day 35, dose 3MedDRA: Injection site pain, Skin discolouration — Feeling: GoodFree text: Injection site remains sore and the skin has turned darkMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
- 2022-01-31
- 2022-05-02
- 2022-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Moderna | No |
| 2 | 2021-03-06 | Moderna | No |
| 3 | 2021-11-01 | Moderna | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): It's day 4 and the redness at the injection site has not gone away neither has the swelling and it feels hard. Does this mean that the injection was subcutaneous? If so, was the vaccine absorbed or do I have to get another booster?
Systemic reaction (other): I'm still concerned that this injection was subcutaneous instead of intramuscular. I'm wondering did the vaccine absorb properly or do I need a fourth dose. I would appreciate an answer.
Release 10 — day 7, dose 3
Systemic reaction (other): Arm remains red at the injection site. I remain concerned about absorption. No Phine call from the CDC to date.
Release 10 — day 28, dose 3
Symptoms: The injection site on my right arm remains sore. No swelling or redness but the skin is dark and my shoulder aches
Release 10 — day 35, dose 3
Symptoms: Injection site remains sore and the skin has turned dark
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Injection site discolouration | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release